Navigation Links
Study Published by Circulation Heart Failure Reinforces Science Behind Shape-HF Cardiopulmonary Exercise Testing Device
Date:4/6/2010

Circulation Heart Failure, a journal of the American Heart Association, recently published the results from a study concluding that ventilator efficiency is more accurate than the current listing criteria for heart transplantation in identifying patients likely to derive a survival benefit from such intervention. The study conclusions reinforce the science behind the Shape-HFTM Cardiopulmonary Exercise Testing system, which measures ventilation parameters including ventilatory efficiency.

(PRWEB) April 6, 2010 -- Circulation Heart Failure, a journal of the American Heart Association, recently published the results from a study concluding that ventilator efficiency (VE/VCO2 slope) is more accurate than the current listing criteria for heart transplantation in identifying patients likely to derive a survival benefit from such intervention. The study conclusions reinforce the science behind the Shape-HFTM Cardiopulmonary Exercise Testing system, which measures ventilation parameters including ventilatory efficiency.

“Cardiopulmonary exercise testing (CPX) has been used for many years to help doctors understand the severity and prognosis in patients with chronic heart failure,” says Dean MacCarter, Ph.D., vice president of clinical studies for Shape Medical Systems Inc. “Peak CPX testing can guide physicians in their clinical decision-making, but conducting CPX tests at such levels comes with its own set of problems such as maximal physical effort by the patient, specialized training, and interpretation challenges.”

“This recent study reinforces the accuracy and reliability of measuring the VE/CO2 slope, which is a core parameter measured by the Shape-HF,” says Clarence Johnson, Shape Medical Systems President. “Further Shape-HF ventilatory efficiency measurements add resolution to the New York Heart Failure Association classification system for heart failure by providing a full range of values that make the assessment more sensitive and specific.”

Ventilatory Efficiency and Heart Transplantation Study Results
A total of 663 chronic heart failure patients who underwent cardiopulmonary exercise testing were tracked for cardiac mortality and heart transplantation. Symptom-limited CPX testing was performed on all patients. Oxygen uptake (VO2), carbon dioxide production (VCO2) and minute ventilation (VE) were measured on a breath-by-breath basis. Peak VO2 was defined as the highest 20- to 30-second average achieved during exercise. Patients were evaluated for the occurrence of death or heart transplantation. Follow-up was right-censored at three years.

Results showed that using a VE/VCO2 slope threshold instead of the current exercise criteria would classify 39 more subjects as high-risk, correctly identifying 19 more patients who died during follow-up, and 16 others who underwent transplantation. VE/VCO2 slope provided significant discrimination between the three years survival of both high- and low-risk patients relative to post-transplant patients. Re-analysis of survival data using death or heart transplantation as endpoint showed similar results. (Ferreira A, Tabet J, Circ Heart Fail, online Feb 22, 2010)

Shape-HF™ Cardiopulmonary Exercise Testing System
The Shape-HF System is the first gas exchange testing device specifically designed for cardiology. It is FDA-approved, easy to use, easy on the patient, and provides clinically relevant data that is easy to understand, reproducible and immediately useful to a cardiologist. Shape-HF measures a patient’s functional capacity and quantifies the severity of dyspnea on exertion. The test takes 15 minutes and involves measuring ventilation parameters while the patient exercises on a treadmill at a very low intensity. The Shape test also quantifies the heart rate response to exercise to determine if it is appropriate and can unmask potential co-morbidities that may adversely affect heart failure prognosis or therapy response.

Shape-HF is the only device that objectively measures cardiopulmonary gas exchange easily and quickly without undue strain on the patient. It can be used in the office setting and provides real-time physiological assessment to help physicians elucidate the physiological underpinnings of dyspnea, objectively assess patient functional classification, monitor therapy response and progress, identify potential co-morbidities, and optimize CRT at exercise levels consistent with patient daily activity. Importantly, Shape-HF exercise testing is cost-effective and easy to use.
   
Shape Medical Systems Inc. is a privately held, St. Paul, Minnesota-based medical device company whose core technology lies in the development and commercialization of products for assessing heart/lung interaction and ventilation in chronic heart failure and other cardiopulmonary disease. Shape's clear mission is to develop products that increase the quality of patients' lives by helping doctors quantify shortness of breath, assess patient functional capacity, optimize drug, device and rehabilitation therapy, and monitor patient progress. Shape testing provides evidence based outcomes. Shape Medical Systems was founded in 2004 and received FDA market clearance for the Shape-HF Cardiopulmonary Testing System in April 2009. The Shape-HF System, testing protocols and applications are protected by patent 7,225,022 and other U.S. and foreign patents issued and pending.

###

Read the full story at http://www.prweb.com/releases/2010/04/prweb3835984.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Casual Sex Doesnt Cause Emotional Damage: Study
2. Study Finds Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks
3. Screening for Spinal Muscular Atrophy Not Cost-Effective: Study
4. New study finds possible source of beta cell destruction that leads to Type 1 diabetes
5. New Study Demonstrates Novel Use of Metabolic Imaging to Locate Sperm in Infertile Men -- Non-Invasive Imaging Procedure May Replace Invasive Techniques such as Testicula
6. Risk of stroke lower for recent Ontario immigrants: study
7. Definitive study confirms chemo benefit in postmenopausal breast cancer
8. Experimental stem cell treatment arrests acute lung injury in mice, study shows
9. Violence is part of the job say nurses as study shows only 1 in 6 incidents are reported
10. Controversial Autism Study Retracted by Medical Journal
11. Study Reveals Impact Of Health Insurance On Hispanics' Attitudes Towards Healthcare Providers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Published by Circulation Heart Failure Reinforces Science Behind Shape-HF Cardiopulmonary Exercise Testing Device 
(Date:6/26/2017)... New Mexico (PRWEB) , ... June 26, 2017 ... ... dysfunction, anorgasmia, and urinary leakage is revolutionizing the way women look and feel ... is tackling the problem of female sexual dysfunction and urinary leakage head on ...
(Date:6/25/2017)... ... ... FCPX LUT Vintage Volume 2 for Final Cut Pro X allows users ... contains 60 different color-grade presets, giving editors multiple options for adding different color options. ... subjects, plus much more. FCPX LUT Vintage Volume 2 is designed for any skill-set ...
(Date:6/25/2017)... Rosa, CA (PRWEB) , ... June 25, 2017 , ... With a heatwave currently bearing ... beach or hanging out at the pool. Being swimsuit ready is easy with laser hair ... – and repeat again can be a burdensome routine when all you want to do ...
(Date:6/24/2017)... ... , ... The weather is heating up and the days are getting longer, ... aware that the summer months provide more than warmer temperatures that are perfect for ... negatively affected from direct exposure to the sun. When it comes to the security ...
(Date:6/23/2017)... ... 2017 , ... Yesterday, U.S. Senate Republicans revealed details of ... replace the Affordable Care Act (ACA). Like the bill narrowly passed by the ... public health insurance program for low-income children, pregnant women, parents of dependent children, ...
Breaking Medicine News(10 mins):
(Date:5/30/2017)... , May 30, 2017 DarioHealth Corp. (NASDAQ: DRIO), a ... solutions, today announced that it will be presenting at the 7th ... AM PT. Erez Raphael , CEO, of DarioHealth will be ... will be held on June 6th & 7th, 2017 at the ... the small / micro-cap space. ...
(Date:5/29/2017)... Biotechnology Ltd. (NASDAQ: APOP ; TASE: APOP), a ... of stem cells, today provided a corporate update and ... 31 st , 2017. "We are ... of 2017," said Dr. Shai Yarkoni, Chief Executive Officer. ... the first blood cancer patient in the recently initiated ...
(Date:5/24/2017)... HAMPTON, Va. , May 24, 2017 /PRNewswire/ ... ivWatch Original Equipment Manufacturer (OEM) Board to enable ... technology with patient monitoring systems, infusion pumps and ... products, OEMs will be able to help health ... care and reduced risks related to IV therapy. ...
Breaking Medicine Technology: